Close Menu
Home » Mission Bio Raises $30M in Series B Financing

Mission Bio Raises $30M in Series B Financing

Dec 13, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Mission Bio said today that it has raised $30 million in a Series B financing round led by Agilent Technologies, Cota Capital, LAM Capital, and Mayfield, bringing its total financing to more than $50 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

A 'Double Whammy'

The Guardian reports that the Mammalian Genetics Unit at the Harwell Institute is to close.

So Much Plastic

Scientific research itself contributes to plastic waste and isn't very sustainable, FiveThirtyEight reports.

With a Little Lemon?

Restaurants in the US may soon serve AquaBounty's genetically modified salmon, according to the Associated Press.

Science Has a Trio of Ruminant Genome Studies and More

In Science this week: three studies from the Ruminant Genome Project, and more.

What's Popular?

In Business News

  1. Personalis Prices $154.9M IPO

  2. Federal Appeals Court Upholds Ruling Invalidating Enzo Biochem Patent

  3. Germany Agrees to Nationwide Reimbursement for Genomic Health Oncotype DX Breast Cancer Test

  4. MGI Tech, Karolinska Institutet Form Microbiomics Research Alliance

  5. BD Files Patent Infringement Suit Against NeuMoDx

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.